Get ahead of standard treatments for MET-positive lung cancer. Participating in a clinical trial for MET-positive lung cancer gives you access to the latest therapies.Call +1 844 627 7246
If your doctor has told you that your lung cancer is MET-positive, it means that you either have too many copies of the MET gene (which is relatively unusual) or that gene has a DNA error called MET exon 14 skipping (which is more common). If you have this MET exon 14 error, cells can’t get rid of growth-promoting MET proteins in an orderly way, which causes them to fuel the spread of cancer.
Having this MET mutation is associated with lung cancer that’s challenging to treat. However, several new drugs that target the MET gene alteration are now available. And new therapies that work by addressing problems caused by having too many copies of MET and MET exon 14 skipping are being studied in clinical trials.
What Are Clinical Trials?
A clinical trial is a research study in which scientists evaluate the effectiveness and safety of new medical treatments. That includes new drugs or novel combinations of drugs for treating cancer and other diseases. Every drug approved by the U.S. Food and Drug Administration had to be tested first in clinical trials.
We combine the power of technology with our dedicated team of medical providers to find you the best treatment options available.Access the free matching tool
Massive Bio offers a quick, easy, and FREE way to find clinical trials for patients like you. With our unique clinical trial matching system and compassionate team, Massive Bio can rapidly match you to clinical trials of new therapies. If you aren’t sure if your lung cancer is MET-positive, that’s okay. Additional testing can help determine your exact diagnosis.
“Massive Bio has gone above and beyond to connect my family with the right care during Covid-19. I really appreciate their staff’s consistent and clear outreach during this process.“
They have a really responsive and hard-working team. It’s a great way to explore clinical cancer trials and find alternative treatments.
I reached out to Massive Bio after learning of a recent breast cancer diagnosis of a family member. From free expert clinical trial matching to patient advocate support, Massive Bio was able to provide me with the necessary resources and knowledge to provide my family member the support they needed during their cancer journey.
My father used the Virtual Tumor Board to get another treatment recommendation. The report was detailed, and the staff answered all our questions. I definitely recommend their services.
I have recommended this to colleagues for patients that could benefit from clinical trials or have exhausted their treatment options and need a second opinion. Massive Bio’s team puts great minds together to find better solutions for patients that might think they have none left.
Massive Bio’s team is amazing. They work tirelessly to help patients and providers. This company truly cares about the work they are doing and the care they are delivering.
Talk to us. Our nurses and patient advocates are here and happy to help you. You are not alone in this fight.Call +1 844 627 7246
Clinical trials test the latest scientific advancements in HER2-Positive cancer treatment. Patients who choose to enroll in trials can receive cutting-edge treatment and high-quality care under the direction of scientists, doctors, and researchers. HER2-Positive cancer patients can gain access to promising drugs and innovative treatments long before they're made available to the public.
At Massive Bio, our goal is to ensure that all cancer patients have access to clinical trials of innovative new treatments that offer hope for improved outcomes. Our unique SYNERGY-AI technology rapidly generates a personalized clinical trial matching report, which is FREE to patients and doctors.